(Bloomberg) -- The National Medical Products Administration has demanded Shanghai regulators conduct on-site inspections at Shanghai Xinxing Medicine after receiving a report that an Intravenous Human Immunoglobulin lot made by the company tested positive for HIV antibodies, the regulator says in a statement.

©2019 Bloomberg L.P.